• Biden calls for 100-day review of strategic supply chains
• Already leading uranium/vanadium producer, UUUU has made significant strides in REE space in 2021
• Energy Fuels on schedule to produce intermediate rare earth product in 2021

In the midst of President Joe Biden’s 100-day review of U.S. strategic supply chains (https://ibn.fm/jc5jW), companies around the country, including Energy Fuels (NYSE American: UUUU) (TSX: EFR), are watching closely for the results. Last year, Energy Fuels, the country’s largest producer of uranium and the leading conventional producer of vanadium, announced plans to enter the rare earth elements (“REE”) space. Just under a year later, the company is about to begin commercial production of an intermediate rare earth product at its facility in Utah. This product contains excellent distributions of the rare earths needed for electric vehicles (“EVs”), renewable energy systems, batteries, technology, and military and defense applications. The supply chain review is intended to boost manufacturing jobs by strengthening U.S. supply chains for advanced batteries, pharmaceuticals, critical minerals and semiconductors; the review will also examine the nation’s reliance on imports of these goods — a potential national security and economic risk that the Biden administration hopes to address. “These are the kinds of common sense solutions that all Americans can get behind,” Biden said, discussing the review. “It’s about resilience, identifying possible points of vulnerabilities in our supply chains and making sure we have the backup alternatives or workarounds in place.” The review appeared to be distinctly bipartisan; an AP article reported that Biden met with Republican and Democratic lawmakers at the Oval Office before signing the order. “This is a critical area where Republicans and Democrats agreed — it was one of the best meetings I think we’ve had so far and we’ve only been here about five weeks,” Biden said. “It was like the old days. People were actually on the same page.” Energy Fuels has a keen interest in the outcome of the analysis. Last year, the company announced its interest in entering the REE market as a complement to its core uranium and recycling businesses. Since that announcement, the company has emerged as a major player in the commercial rare earth business. Its initial goal was to enter the commercial REE business in H1 2021, working to supply up to 50% of U.S. rare earth demand contained in a mixed REE carbonate over the next few years. The company is expected to soon begin processing its first monazite ore at its White Mesa Mill in Blanding, Utah, and producing a marketable mixed rare earth element carbonate. If successful Energy Fuels will be producing a rare earth product at a stage more advanced than any other U.S. company. This work represents a crucial step toward re-establishing a fully integrated U.S. rare earth element supply chain. In addition, the company has plans to install REE separation and additional downstream capabilities over the next few years. These plans can be implemented within the company’s existing infrastructure (https://ibn.fm/gSXQP). With its expansion into the growing REE market, strong balance sheet, diverse business opportunities, and all debt paid off last year, the company is leveraging a robust business model that allows it to be well positioned to capitalize on the increasing momentum for the REE space. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• Shark Tank survivor James Martin sells Copa Di Vino to SBEV, 13,000 new retail locations in acquisition agreement
• Copa Di Vino is ready-to-drink portable wine glass that doesn’t require bottle or corkscrew
• After Shark Tank appearance, Copa Di Vino generated tens of millions of dollars in revenue
• SBEV develops, accelerates, grows pre-existing brands for profitable exit events

After turning down multiple offers on Shark Tank years ago, James Martin, the show’s “most infamous entrepreneur” and founder of Copa Di Vino, ultimately sold his business to Splash Beverage Group (OTCQB: SBEV), a portfolio company of successful beverage brands (https://ibn.fm/CKk7L). SBEV management is confident it can accelerate the Copa Di Vino brand for massive expansion through its top-tier production, supply chain and global distribution capabilities. “The acquisition adds a remarkable revenue stream to Splash’s bottom line and includes Copa Di Vino’s proprietary packaging technology, an innovation suitable for a number of applications across the Company’s growing portfolio of beverage brands and industry solutions,” said SBEV CEO Robert Nistico. After turning down the sharks – not once, but twice – Copa Di Vino went on to generate tens of millions of dollars in revenue. Fueled by Martin’s passion for wine and technological expertise, the brand features innovative packaging that allows winemakers to ship their products in a single-serve format, allowing connoisseurs to consume and carry wine in a convenient, portable design. “That’s never been done with wine before, and I grant him that was a good move,” said Kevin O’Leary, renowned venture capitalist and star of Shark Tank. Packaged wine in sizes below 500ml are gaining rapid traction across the United States, according to IWSR Drinks Market Analysis (https://ibn.fm/5qxI8). Single-serve adult beverages like Copa Di Vino’s “wine in a glass” are growing in popularity for consumption at outdoor events due to their easy portability and non-breakable nature—especially in light of COVID-19’s accelerated impact on carry-out services and outdoor seating availability at eateries. SBEV’s acquisition of Copa Di Vino is leveraging this trend through new distribution channels that include the Anheuser-Busch Network, 13,000 retail locations across various chains, and new e-commerce outlets. “As the large venue segment reopens for sports, concerts and other live audience events, we expect to capture meaningful sales volume as this packaging is a perfect fit for stadiums, theaters and other large venues, and the patented packaging technology is not limited to wine,” said Nistico. “We anticipate making use of the versatile utility here in a very big way as market opportunities continue to emerge and resurface.” Among SBEV’s current portfolio are three other unique brands that include TapouT Performance – a natural isotonic hydration & recovery sports drink, Salt Naturally Flavored Tequila, and Pulpoloco Sangria – a premium crafted sangria in an eco-friendly biodegradable catocan. Led by an expert management team with a track record of success, SBEV’s strategy is to rapidly develop and accelerate pre-existing brands that can be profitably exited for cash events. For more information, visit the company’s website at www.SplashBeverageGroup.com. NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

• Every product features three parts: dosing device, formulation accessory and mobile app
• HIPPA-compliant cloud collects data along each step that is essential in tailoring personalized treatment plan
• RYAH offers multi-product ecosystem that provides remote-health solutions in patient treatment

RYAH Group a digital health-care analytics and technology company, has developed an ecosystem of IoT products in its mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments (https://ibn.fm/1wvz4). Every product features three parts: the device, the formulation accessory (QR labeled product) and the mobile application. These parts work together to control the dosing while also capturing important data that can lead to breakthroughs in plant-based medicine. Every RYAH dose-measuring product has an innovative dose-control solution. Using QR-labeled products, patients can track what they use and evaluate what dosing parameters work best for each product. The QR labeling allows for advanced session tracking and journaling and is designed to ensure safety. Patients can then control and rate the effectiveness of each session on RYAH’s mobile app. This allows the user to tweak future doses to provide more optimal results. The HIPPA-compliant cloud collects data along each step of the ecosystem that is essential in tailoring a personalized treatment plan moving forward. The suite of products also provides critical information for future treatment of patients with various medical conditions. The company releases a monthly in-depth analytical report sharing publicly identified trends and how dosing affects consumer outcomes. RYAH ecosystem includes a range of IoT devices, including Smart Patch, Smart Inhaler and the upcoming Smart Pen, as well as RYAH MD remote health platform. The Smart Patch allows users to access on-demand relief and schedule doses based on when their symptoms are the most severe. After using the QR labeled product, the mobile app’s user records how well the patch worked. Users can then review stats and create an optimized schedule for later use. It creates an organized record of what patches worked best. RYAH’s Smart Inhaler allows users to control how much is inhaled, ensuring consistent and predictable results. Temperature and dosage can be controlled, and then the effects can be recorded in the mobile app. Statistics can be reviewed, and dosing can be altered accordingly for future uses. The Smart Pen allows for oral consumption and can uniquely dose up to three different liquid formulations for a highly personalized effect. The dose can be added to a drink or directly into the mouth. The app is then used to record the effects of the dose for review to make any changes for future dosing. RYAH MD is a service that allows clinicians to remotely monitor and control patients’ dosing regimens with the before-mentioned dose-measuring products. It provides necessary information that doctors can analyze to learn how different dosing variables affect outcomes. RYAH MD allows the doctor to recommend parameters on the smart devices for dosing, review the information in real-time, and make changes remotely to the doses delivered. It will enable doctors to monitor their patients and ensure that they are following the recommended procedures. RYAH Cloud captures all of the structured and unstructured data from the dosing products and the mobile apps and analyzes the information. This allows doctors and clinics to develop more personalized therapies that can reshape our medical future. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH

• The United States continues to experience acts of anger and hatred stemming from sharp partisan divides that are often ideological and historical in nature
• California-based Knightscope has been developing a line of autonomous security robots (“ASRs”) designed to monitor activities at clients’ properties and report concerns to security personnel
• The robots come in one stationary and two mobile models capable of using AI to monitor, record and transmit data stemming from features including facial recognition, heat sensors, audio and data transmissions and video in low-light circumstances
• Knightscope’s founders have developed a mission of making the United States the safest country in the world through client contracts for the ASRs

Recent years have seen a growing polarization of societal groups across the planet, driven not only by political forces but now also by frustrations over health sciences and reawakened discord in race relations that sometimes lead to violent interactions between people on ideological grounds rather than the physical needs that so commonly spawn crime. It’s a trend that has also awakened a call for better vigilance from Autonomous security robot (“ASR”) developer Knightscope. “Americans are by and large entrenched in their political and cultural tribes, and virtually nothing can budge them out of their partisan voting lanes,” Time magazine intoned following last year’s elections in the United States. “America remains deeply polarized, few voters are truly persuadable, and angry gridlock will likely dominate Washington D.C.” (https://ibn.fm/CNLuU). “Sovereign power of the people does not mean that mobs and other groups of people can intervene to intimidate or force government action,” a senior leader in The Church of Jesus Christ of Latter-day Saints told frequently partisan U.S. members in an appeal for unity during a religious broadcast earlier this month. “There are many political issues, and no party, platform or individual candidate can satisfy all personal preferences. Each citizen must therefore decide which issues are most important to him or her at any particular time … It may require changing party support or candidate choices, even from election to election” (https://ibn.fm/JQBuw). Last year’s political protests and rioting over police powers gave way to the storming of the U.S. Capitol by malcontents in January while Congress was in session, and then the mass shootings in March that marked the first such incidents to take place since the pandemic brought many aspects of normal daily interaction to a standstill. And the discord is further evident in medical technology pioneer Moderna’s recent declaration that it believed it was necessary to spend more than $1 million on security for its CEO and other company executives as it was in the process of rolling out one of the leading vaccines to combat the pandemic. “In response to the increased profile of our company and our executives as we pursued the development of a vaccine against COVID-19, in 2020 the company authorized the provision of personal and home security services to certain” executives, the company’s most recent proxy filing states, as reported by Trade magazine Security (https://ibn.fm/dddEb). Knightscope founder and CEO William Santana Li, a New York City native, said he became “profoundly pissed off” by the terrorist attacks on America’s infrastructure back in 2001, and made it his personal mission to help the country’s private entities and their government become more secure. The company has rolled out three models of ASRs so far — a stationary, in-building K1 robot that is able to monitor for a variety of high-tech data points, ranging from a 360-degree video feed’s facial recognition prowess to data broadcasts and thermal fluctuations. The company’s K3 model in an indoor mobile unit designed to patrol hallways and office space as desired by clients, while the K5 unit takes Knightscope’s ASR sentry offering outside to patrol the grounds of the clients’ property. Testimonials about the K5’s performance at a Las Vegas apartment complex include a police department report that the property went from being in the top three for 911 calls in the area to no longer being in the top 10. (even though the ASRs are simply high-tech non-defensive, unarmed monitors capable of observing, recording and communicating requested information via the Knightscope Security Operations Center). https://ibn.fm/6st3U. For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• HempFusion Wellness Inc. has been eying the Asian market for some time, as indicated in its latest operational update to investors
• With the recent announcement that it had received conditional approval to launch its CBD products on Tmall Global, HempFusion looks set to meet its other expansion targets
• The announcement follows a similar move by its wholly owned subsidiary, Probulin Probiotics, and confirms HempFusion’s reliance on Probulin as a gateway to international markets

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) recently announced it had received conditional approval to launch its CBD products on Tmall Global, the world’s largest cross-border online marketplace. This latest move by the Denver-based leading health and wellness CBD company is backed by a well-thought-out expansion strategy as it follows a similar move by its wholly owned subsidiary, Probulin Probiotics, LLC. In a sponsored Financial Post article earlier this year (https://ibn.fm/9h3BY), Dr. Jason Mitchell, N.D., HempFusion’s co-founder and CEO noted that Probulin serves as a strong foundation for HempFusion to increase its domestic and international distribution. “Probulin’s distribution presence in our key markets gives us a lot of runway opportunities to execute our plan to expand HempFusion into multiple markets that are not readily available to other CBD companies,” he stated. The expansion into the Asian market, which has long been in the company’s sights as indicated in an operational update to investors released April 5 (https://ibn.fm/8cY1q), demonstrates the reliance on its subsidiary very clearly because back in March, HempFusion launched Probulin products on Tmall Global (https://ibn.fm/94DHu). Thus, based on the CEO’s statement, the earlier launch was to pave the way for the entry of the parent company’s products into the Asian market. With the conditional approval given, HempFusion’s OTC topicals, including Acne Relief, Eczema Relief and Sports Pain Relief Creams, Pain Relief and Sports Pain Relief Balms, Pain Relief Gel and Wound Ointment, are expected to launch on Tmall soon, with more products expected to follow. “To be one of the first publicly traded CBD companies on the platform provides us with significant competitive advantages that have the potential to add considerable revenue to our company,” said HempFusion’s Chief Revenue Officer Jon Visser of the approval (https://ibn.fm/S4aFQ). On his part, Dr. Mitchell noted that introducing the company’s products on Tmall, the premier Asian e-commerce platform, had been a major focus in its strategic expansion plan. Notably, Tmall will offer HempFusion the potential of reaching more than 750 million new consumers. “We are now accessing one of the largest online consumer groups in the world with products formulated with approved drug monograph ingredients such as menthol for ailments such as pain. These products have already performed as best in class in select retailers in the United States, and we’re excited to see that follow through in the world’s largest market,” he continued. The latest step is welcome news for a company that experienced a tumultuous 2020, per the operational update. “COVID and continued lack of clarity from the FDA related to official regulatory guidance for CBD used in dietary supplements, foods and beverages has made 2020 a challenging year. However, these challenges have led to strategic changes, establishing the foundation for HempFusion to succeed in 2021 and beyond,” the update reads. The well-thought-out expansion into the Asian market, backed by the positioning of Probulin as a foundational component in its parent company’s expansion drive, is perhaps one of the strategic changes HempFusion has made. In other equally positive news, CBD.U became the first U.S.-based CBD and wellness products company to list directly on the Toronto Stock Exchange (“TSX”) following the completion of a US$17 million initial public offering (“IPO”) in January 2021. Additionally, the company has witnessed an increase in online sales from 6% to 24% in the few months preceding the April 2021 update. The update also noted that HempFusion was targeting international markets such as Latin America, Canada, India, China, and the rest of Europe (besides Ireland and the UK, where the company has already set up shop). With the launch into China already cast in stone, HempFusion looks focused on meeting its expansion targets and generating more revenue as a result. “The future is bright,” the operational update concluded. For more information, visit the company’s website at www.HempFusion.com/corporate-information. NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/CBDHF

• Precious and base metals producer Asia Broadband, Inc., reported its highest-ever annual gross profits in its recent 2020 year-end financials report
• Asia Broadband has been building its portfolio of gold mining interests along Mexico’s western coastline amid the economic ravages of the COVID pandemic
• Asia Broadband recently launched a gold-backed cryptocurrency tied to $30 million in gold currently held by the company
• The company has an existing pipeline of gold production from its initial Mexico site to high resource demand and abundant investment capital in Asia

Precious and base metals producer and gold-backed stablecoin developer Asia Broadband (OTC: AABB) has announced its 2020 year-end financial results, including news of a record annual gross profit of $16.8 million, as well as an increase in an upcoming stock dividend celebrating the company’s growth. The news release announcing AABB’s all-time high gross profit noted that the returns are evidence the company was successful even during a year when the world’s economic climate was battered by the spread of a novel coronavirus pandemic. The Las Vegas-based company is also building on that success by shifting its focus to add a new acquisition in Mexico’s state of Colima to its existing vertically integrated mineral resource production pipeline sourcing from Mexico’s Guerrero state to a high-interest outlet in Asia (https://ibn.fm/nBaFY). “The terms of the (Colima) property purchase were a lump-sum payment of $1.1 million for a 100% interest in the 100 hectare (247-acre) parcel with the ability to purchase additional adjacent property areas in the future. Previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property in this prolific mineral production region of Mexico,” the company’s 2020 annual financials report states (https://ibn.fm/ivtbT). The Colima property is a fraction of the Guerrero property’s size, but the Colima acquisition carried a price tag more than double that of the initial concessions and subsequent expansion in Guerrero, reflecting its position as a high-potential mineral property. AABB has also signed a letter of intent to buy a third historic gold mine property and off-site facilities in the neighboring state of Jalisco (https://ibn.fm/0wccF). On March 30, the company announced its management and board approved increasing a planned stock dividend distribution by 10 percent to one dividend share for every 45 shares owned, and extending the effective date of the distribution to shareholders of record in Asia Broadband to May 3 of this year. “AABB would like to reward its loyal shareholder base for their patience, continued support and interest in sharing the success and growth of the Company,” the announcement states (https://ibn.fm/DDVXT). Asia Broadband is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets following the purchase of the Guerrero mining concession in 2015, which has been the site of small-scale surface and underground mining production since 1953. The company has been in the process of updating its website and management infrastructure, and in late March launched its gold-backed cryptocurrency token AABBG. Recent years have seen a proverbial and literal gold rush among investors wanting to snap up cryptocurrencies as an alternative form of trade not bound to the government fiat of the world’s nations, despite the roller coaster fluctuations of the crypto market (https://ibn.fm/jX8lf). Stablecoins such as the one launched by Asia Broadband are valued by many investors as cryptocurrencies that don’t have as much price volatility as Bitcoin and other altcoins because of the tethering to physical assets. Government fiat tethers such as the one announced in late March by Visa Inc. can produce successful stablecoins (https://ibn.fm/jUKAo), but gold persists as the most popular alternative for fiat-free trade. Asia Broadband’s stablecoin entry is currently backed by $30 million in physical gold from its properties, with the price of each token tied to whatever the existing price of one-tenth (0.1) gram of gold may be plus a 2 percent transaction fee (https://ibn.fm/CmJrY). Buyers will need to hold existing cryptocurrencies to purchase AABBG and the purchase will be finalized when cryptocurrencies from third-party wallets are deposited into the AABB wallet in exchange for AABBG. AABBG tokens cannot be exchanged for other cryptocurrencies within the AABB Wallet. AABBG tokens cannot be exchanged for other cryptocurrencies within the AABB Wallet until the company launches its proprietary Exchange version of the AABB Wallet in the coming months. At this time, the AABBG token’s potential price appreciation will be determined by market demand. For more information, visit the company’s website at www.AsiaBroadbandInc.com. NOTE TO INVESTORS: The latest news and updates relating to AABB are available in the company’s newsroom at https://ibn.fm/AABB

• Global tobacco market reached $818 billion in 2019; U.S. market forecast to reach $50.9 billion this year
• Largest global tobacco category is combustible cigarettes, due in part to the sensory impact of smoking
• TAAT has created alternative cigarette that retains sensory impact with margins superior to traditional cigarettes for distributor, retailer

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQX: TOBAF) has developed TAAT, a alternative to traditional cigarettes with potential to disrupt the highly lucrative tobacco market with a choice that delivers a pleasurable smoking experience without the nicotine or tobacco. Beyond Tobacco(TM), the cigarette’s base material mimics the tobacco smoking experience without side effects. This allows the company to capitalize on cost-effective digital strategies unavailable to nicotine products. Through the combined efforts of a scalable production platform, a successful Ohio and e-commerce rollout, and the experience of a strong management team, TAAT is already seeing high margins. But these numbers don’t just benefit TAAT. The company has created an ecosystem that provides distributors and retailers with superior returns above tobacco-based cigarettes. In 2019 the global tobacco market, even with the widespread education regarding harmful side effects, reached $818 billion. The United States alone is expected to reach an estimated $50.9 billion in 2021. The largest global tobacco category is combustible cigarettes. Why? The sensory impact of smoking has played a big part in why consumers keep returning. The BeyondTobacco experience closely mimics every sensory element of smoking a tobacco cigarette. TAAT has captured the experience through packaging, scents, crackling sounds, a tobacco taste and even the motor habits, such as hand to mouth and flicking of ashes. The company has made an attractive alternative cigarette product that consumers are reaching for. Smokers don’t just use cigarettes for the nicotine. For many, it is about the ritual and the experience. TAAT is offering an alternative experience without compromise. One of the many benefits of TAAT is the lower price point. The company is able to leverage existing tobacco sales channels and use state-specific and region-specific distributors. For both the distributor and retailer, TAAT provides an exciting new product with margins superior to that of traditional cigarettes while also passing on the savings to the consumer. For more information, visit the company’s websites at www.TryTAAT.com and www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

• Uranium Energy Corp’s Executive Vice President, Scott Melbye, presented testimony to Senate Committee on Energy & Natural Resources
• During his testimony, Melbye provided detail on current state of American nuclear energy industry as well as challenges being faced by the sector
• While nuclear power is an integral part of United States electricity framework, the country is now nearly completely dependent on foreign uranium imports to fuel its nuclear generators
• Melbye urged Congress to work towards increasing domestic uranium production within United States while simultaneously, building out recently established strategic uranium reserve

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, announced that the company’s executive vice president and current president of the Uranium Producers of America, Scott Melbye, recently presented testimony at the Full Committee Hearing on Nuclear Energy for the Senate Committee on Energy & Natural Resources on March 25, 2021 (https://ibn.fm/dEX9b).

Boasting 36 years of experience within every facet of the international nuclear fuel cycle, ranging from the production and global marketing of uranium to its use as a clean-energy fuel, Scott Melbye testified as to the current state of the United States’ nuclear energy industry as well as the challenges facing the sector as a whole.

Nuclear power currently provides electricity to one in five American homes while also accounting for half of the United States’ carbon-free power. However, Melbye stated, the American nuclear power industry is dangerously close to losing its uranium fuel industrial base. The United States is now nearly completely dependent on foreign uranium imports, with almost half of the fuel used by the United States’ commercial reactor fleet being sourced from state-owned entities in Russia, Kazakhstan, and Uzbekistan. Meanwhile, the nation’s domestic enrichment capacity is close to non-existent; the sole U.S. conversion facility in Illinois has been idle since 2017 and will only begin to restart operations in 2023.

Nonetheless, as Melbye elaborated, it is not too late to change the current state of affairs, with the United States possessing over one billion pounds of uranium in known and likely deposits. Uranium Energy Corp has worked towards the development of a variety of uranium project sites in locations such as Texas, New Mexico, Colorado, Arizona and Wyoming. Utilizing historical mineral and oil & gas exploration data, UEC has been able to target and acquire properties which have already been subject to exploration and development by senior energy firms in the past, thereby dramatically lowering the company’s overall development expenses and ultimate production costs.

At their flagship Texas and Wyoming projects and operations, the low-cost and environmentally friendly mining technology called in-situ recovery (ISR) will be used by UEC to competitively supply uranium to both global utilities and the needs of the U.S. government.

Accordingly, Melbye pressed upon the urgent need for the U.S. administration and Congress to move swiftly towards purchasing uranium this year for the recently established strategic uranium reserve and fully fund the program for FY2022. The anticipated purchases would serve to preserve the nation’s industrial base, guard against global supply disruptions, and create a source of U.S.-origin uranium for defense needs.

For more information, visit the company’s website at www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

• ISW Holdings shaping up to become leader in rapidly growing telehealth and home healthcare market, appears ready for post-COVID world
• Company is eyeing new growth opportunities in telehealth, considering potential acquisition of autism therapy telehealth solution
• ISWH remains committed to tapping into emerging market trends, seizing high-potential opportunities

ISW Holdings (OTC: ISWH), a global brand-management holdings company with commercial operations in telehealth and cryptocurrency mining, stands ready for the post-COVID era as the telehealth sector takes a more central stage. The company recently announced the official launch of TeleCare Home Health LLC, its wholly owned telehealth and home health-care subsidiary, in a bid to meet pressing needs created by the pandemic (https://ibn.fm/r6IEo). Quick to recognize and respond when opportunities emerge, ISWH appears well positioned to become a leader in the $300 billion global home healthcare market. The sector has seen rapid growth over the past year and is projected to grow at a CAGR of 7.9%, reaching $515.6 billion by 2027. ISW Holdings believes the projected growth numbers could be even more optimistic in the space following the pandemic. Although COVID brought disruption at an unprecedented scale, some changes are expected to stay even when the pandemic wanes. Broader acceptance of telehealth is one of them. Telehealth technology has made inroads that, when coupled with deregulation of external health management and more general acceptance of nontraditional healthcare formats, have created an environment more suitable for remote healthcare over the past year. “The pandemic crisis has sparked many changes, and some of them will be with us for the long term,” said Alonzo Pierce, president and chairman of ISW Holdings. “A great example of one such change is the way we interface with our health-care resources. Regulatory and cultural changes have opened up a more efficient path forward, and TeleCare will be one of the front-line players helping to shape that future.” Confident in the telemedicine’s upside potential, ISWH has recently renegotiated its relationship with Paradigm Home Health, its telehealth and home health-care joint venture partner, to increase the company’s share of sales from 50% to 70% (https://ibn.fm/daLXo). But the company will not stop there. Poised to seize lucrative market opportunities, ISWH plans its next steps to capitalize on the solid telehealth momentum. The company is considering a potential acquisition of an autism therapy telehealth solution, believing that an unmet market need exists in this space. As a diversified portfolio company, ISW is committed to investing in essential business lines and disruptive industries that serve high-potential consumer demands. Focused on anticipating marketplace needs, the company invests in businesses exposed to emerging market trends, supporting them with a structure that can respond to large scalability requirements. “TeleCare Home Health gives us a proprietary footprint in the vastly growing telehealth and home health-care market,” said Pierce. “With demand for telehealth and home health-care services increasing due to our aging population, we believe we are well-positioned to offer high-quality, effective services to meet the rapidly growing demand for more patient-centric services through value-based health care. We are confident that today’s official launch of TeleCare Home Health is the beginning of a company focused on providing a solution to what will soon become a half-trillion-dollar marketplace.” For more information, visit the company’s website at www.ISWHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

• Bioscience technology accelerator XPhyto Therapeutics Corp. is working with development partner 3a-diagnostics GmbH to roll out its pandemic-related virus diagnostic tool for the European market planned in April
• The test solution, dubbed “Covid-ID Lab,” received European regulatory approval last month
• XPhyto’s product is designed to be portable and rapid in its response time to help decrease testing operation costs and increase convenience of use
• News reports about the COVID-19 pandemic reflect a growing optimism that vaccine, mask and distancing protocols may be helping to drive down infection rates, although the reports note the virus continues to have a deadly effect on many people
• Government and industry leaders have been looking for accurate and rapid diagnostic tools that may make it easier for travel operations and other businesses to resume robust activity despite the continued presence of the infectious virus

Vaccine distribution to millions of people and reports of declining rates of COVID-19 infection are generating optimism in the United States that the health crisis and its economic devastation are beginning to retreat before a modern medical technology assault, even as health officials continue to issue warnings that the deadly virus and its variants are still very active (https://ibn.fm/cl8Vk).

Bioscience technology accelerator XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is now ready to launch its own solution for improving detection of the virus responsible for the worldwide pandemic. The company announced on March 18 that European regulatory officials have approved its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system, known more simply as “Covid-ID Lab,” as a commercial in vitro diagnostic device (CE-IVD) designed to help industry professionals and government agencies screen for the virus.

Covid-ID Lab was developed by XPhyto’s exclusive German diagnostics development partner, 3a-diagnostics GmbH  to be a COVID-19 testing system that is rapid, accurate and portable, granting it marketability as a product with decreased operating costs and increased convenience.

“Our test is one of the fastest PCR-based COVID-19 tests currently approved. With a sample collection to result time of 25 minutes, Covid-ID Lab combines the speed of a rapid screening test with the accuracy of a PCR diagnostic,” XPhyto CEO and Director Hugh Rogers stated (https://ibn.fm/Fi0Mw). “Covid-ID Lab is designed for point-of-care testing, particularly in satellite and small-scale labs, such as transportation hubs, borders, care facilities, schools, pharmacies, and hospitality settings.”

The company announced in February that it had quickly formed a team of expert marketing leaders to launch Covid-ID Lab in anticipation of its approval under internationally agreed-on ISO 13485 quality standards. The market launch team consists of world-class clinical and pharmaceutical executives and service providers who have led company growth in the medical diagnostic industry from inception to over 500 million Euro per year in multinational sales, according to a company news release about the team’s work (https://ibn.fm/plVjO).

Sales rollout of the diagnostic tool is planned for April across Europe and official discussions about distribution and wholesale opportunities are under way with potential partners in the Middle East as well.

“We are extremely fortunate to now have a team with deep expertise in medical diagnostic product commercialization,” Rogers stated. “We are working hard to put the Company in the best possible position to execute on our business strategy.”

XPhyto also is developing an expanded portfolio of oral biosensor screening tests that will help clients detect other bacterial and viral infectious diseases, such as influenza A, group A strep, periodontitis and the H1N1 and H5N1 flu variants responsible for previous pandemics. The company is aiming for its first product launch under the portfolio in late 2021.

XPhyto has research and development operations in North America and Europe but its focus is the European market at this time.

For more information, visit the company’s website at www.XPhyto.com.

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF